AI Quick Read Alembic Pharmaceuticals Ltd is expanding its branded speciality drugs portfolio in the US as part of a ‘twin engine play’ to boost growth in the market as generic pricing pressure ...
Alembic Pharmaceuticals Ltd on Friday reported a 29 per cent rise in consolidated net profit at Rs 202.7 crore in the fourth quarter ended March 31, driven by revenue growth across segments. The ...
Alembic Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Methotrexate Injection USP, the company ...
International consultancy Accenture announced last week that it had invested in AI startup Alembic, kickstarting a partnership that will leverage the technology to better measure the effectiveness of ...
Alembic Technologies raises $145M and buys an Nvidia-powered supercomputer to accelerate ‘causal AI’
Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...
Alembic, a startup that offers AI-powered data analytics for marketers, said it has raised $145 million in a fundraising round that values the company at $645 million. Alembic’s software is designed ...
# 1) Create and activate a local virtual env python -m venv .venv && source .venv/bin/activate # 2) Install core web stack # - fastapi[all]: FastAPI + Starlette + Pydantic v2 # - uvicorn[standard]: ...
Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter
Three Indian drugmakers issued separate U.S. drug recalls in recent weeks. (Stock Photo ) A trio of Indian drugmakers—Alembic Pharmaceuticals, Sun Pharmaceutical and Glenmark Pharmaceuticals—issued ...
Bayer AG, Pfizer Inc., and Eli Lilly & Co. led a pair of lawsuits alleging Alembic Pharmaceutics and its US unit infringe a total of seven patents in copying Bayer’s Vitrakvi cancer treatment. Alembic ...
Aug 5 (Reuters) - India's Alembic Pharmaceuticals (ALEM.NS), opens new tab reported a 14.6% rise in consolidated profit for the first quarter on Tuesday, driven by strong sales in the U.S. and India.
Alembic Pharmaceuticals has received final approval from the USFDA for its generic Carbamazepine extended-release tablets, used for treating seizures and nerve pain. The approval covers 100 mg, 200 mg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results